Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma. (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-019-10898-3
PubMed Identifier: 31308377
Publication URI: http://europepmc.org/abstract/MED/31308377
Type: Journal Article/Review
Volume: 10
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723